Patents by Inventor Luisella Toschi

Luisella Toschi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
    Patent number: 10759794
    Abstract: The present application relates to novel 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of respiratory disorders including, sleep-related respiratory disorders such as obstructive sleep apnoeas and central sleep apnoeas and snoring.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: September 1, 2020
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Martina Delbeck, Michael Hahn, Thomas Müller, Heinrich Meier, Klemens Lustig, Johanna Mosig, Luisella Toschi, Udo Albus, Doris Gehring, Björn Rosenstein
  • Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same
    Patent number: 10414765
    Abstract: The present application relates to novel (2-phenylimidazo[1,2-a]pyridin-3-yl)methyl-substituted perhydropyrrolo[3,4-c]pyrrole derivatives, to methods for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of respiratory disorders including sleep-related respiratory disorders such as obstructive sleep apneas and central sleep apneas and snoring.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: September 17, 2019
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Martina Delbeck, Michael Hahn, Thomas Müller, Heinrich Meier, Klemens Lustig, Johanna Mosig, Luisella Toschi, Udo Albus, Doris Gehring, Björn Rosenstein
  • 2-PHENYL-3-(PIPERAZINOMETHYL)IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS BLOCKERS OF TASK-1 AND TASK-2 CHANNELS, FOR THE TREATMENT OF SLEEP-RELATED BREATHING DISORDERS
    Publication number: 20190062326
    Abstract: The present application relates to novel 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of respiratory disorders including, sleep-related respiratory disorders such as obstructive sleep apnoeas and central sleep apnoeas and snoring.
    Type: Application
    Filed: December 7, 2016
    Publication date: February 28, 2019
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Martina DELBECK, Michael HAHN, Thomas MÜLLER, Heinrich MEIER, Klemens LUSTIG, Johanna MOSIG, Luisella TOSCHI, Udo ALBUS, Doris GEHRING, Björn ROSENSTEIN
  • SUBSTITUTED PERHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND THE USE OF SAME
    Publication number: 20180370965
    Abstract: The present application relates to novel (2-phenylimidazo[1,2-a]pyridin-3-yl)methyl-substituted perhydropyrrolo[3,4-c]pyrrole derivatives, to methods for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of respiratory disorders including sleep-related respiratory disorders such as obstructive sleep apneas and central sleep apneas and snoring.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 27, 2018
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Martina DELBECK, Michael HAHN, Thomas MÜLLER, Heinrich MEIER, Klemens LUSTIG, Johanna MOSIG, Luisella TOSCHI, Udo ALBUS, Doris GEHRING, Björn ROSENSTEIN
  • Apoptin-associating protein
    Patent number: 7741440
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapies, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is completely or partially non-functional.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: June 22, 2010
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn, Bertram Weiss, Luisella Toschi
  • 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
    Patent number: 7563924
    Abstract: The present invention relates to 9-chloroprostaglandin derivatives of the general formula I which may be advantageous for the treatment of fertility problems.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: July 21, 2009
    Assignee: Schering Aktiengesellschaft
    Inventors: Bernd Buchmann, Daryl Faulds, William Guilford, Gernot Langer, Judy Li, Bernhard Lindenthal, Werner Skuballa, Luisella Toschi
  • Apoptin-associating protein
    Publication number: 20080103099
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapies, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is completely or partially non-functional.
    Type: Application
    Filed: October 1, 2007
    Publication date: May 1, 2008
    Applicant: Leadd B.V.
    Inventors: Mathieu Noteborn, Astrid Danen-van Oorschot, Jennifer Rohn, Bertram Weiss, Luisella Toschi
  • Apoptin-associating protein
    Publication number: 20080058267
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapies, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is completely or partially non-functional.
    Type: Application
    Filed: July 16, 2007
    Publication date: March 6, 2008
    Inventors: Mathieu Hubertus Noteborn, Astrid Adriana Danen-van Oorschot, Jennifer Rohn, Bertram Weiss, Luisella Toschi
  • 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
    Publication number: 20070203096
    Abstract: The present invention relates to 9-chloroprostaglandin derivatives of the general formula I which may be advantageous for the treatment of fertility problems.
    Type: Application
    Filed: November 20, 2006
    Publication date: August 30, 2007
    Applicant: Schering Aktiengesellschaft
    Inventors: Bernd Buchmann, Daryl Faulds, William Guilford, Gernot Langer, Judy Li, Bernhard Lindenthal, Werner Skuballa, Luisella Toschi
  • Fluorenes and carbazoles as ligands of the EP2 receptor
    Publication number: 20070197524
    Abstract: The present invention relates to carbazoles/fluorenes, to processes for their preparation and to their use for preparing pharmaceutical agents for the treatment of disorders connected to the EP2 receptor.
    Type: Application
    Filed: December 21, 2006
    Publication date: August 23, 2007
    Inventors: Nico Brauer, Bernd Buchmann, Christoph Huwe, Bernhard Lindenthal, Gernot Langer, Olaf Peters, Gerd Schubert, Ulrich Bothe, Luisella Toschi, Michaele Peters-Kottig
  • Apoptin-associating protein
    Patent number: 7256274
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) nonfunctional.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: August 14, 2007
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn, Bertram Weiss, Luisella Toschi
  • Apoptin-associating protein
    Publication number: 20030091996
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) nonfunctional.
    Type: Application
    Filed: December 8, 2000
    Publication date: May 15, 2003
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A.M. Danen-Van Oorschot, Jennifer Leigh Rohn, Bertram Weiss, Luisella Toschi
  • Membrane receptors for steroids and sterols
    Publication number: 20030045699
    Abstract: Four splice variants of a membrane receptor for steroids and sterols and their use are described.
    Type: Application
    Filed: April 26, 2002
    Publication date: March 6, 2003
    Inventors: Bertram Weiss, Monika Lessl, Luisella Toschi
  • Three new members of the cytokine receptor family class 2
    Publication number: 20030022827
    Abstract: This invention relates to three new members of the cytokine receptor class 2 family and their pharmaceutical use.
    Type: Application
    Filed: September 25, 2001
    Publication date: January 30, 2003
    Inventors: Bertram Weiss, Robert Sabat, Khusru Asadullah, Luisella Toschi